AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery

Adeno-associated virus (AAV) is one of the most commonly used vectors for gene therapy, and the applications for AAV-delivered therapies are numerous. However, the current state of technology is limited by the low efficiency with which most AAV vectors transduce skeletal muscle tissue. We demonstrat...

Full description

Bibliographic Details
Main Authors: Cody B. Jackson, Audrey S. Richard, Amrita Ojha, Kimberly A. Conkright, Jeffrey M. Trimarchi, Charles C. Bailey, Michael D. Alpert, Mark A. Kay, Michael Farzan, Hyeryun Choe
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S232905012030231X